Article
Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Apr 2008
Lasota Jerzy, Corless Christopher L, Heinrich Michael C, Debiec-Rychter Maria, Sciot Raf, Wardelmann Eva, Merkelbach-Bruse Sabine, Schildhaus Hans-Ulrich, Steigen Sonja E, Stachura Jerzy, Wozniak Agnieszka, Antonescu Cristina, Daum Ondrej, Martin Javier, Del Muro Javier Garcia, Miettinen Markku
Abstract excerpt
Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms driven by oncogenic, mutational activation of KIT or platelet-derived growth factor receptor alpha (PDGFRA). GIST-specific KIT or PDGFRA mutations have been linked to tumor location, tumor cell morphology and clinical behavior. The purpose of this study was to evaluate the clinicopathologic profile of GISTs that have KIT exon 13 or exon 17...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
